Medication info
Misaltantwin Tablet 80/5 mg (Telmisartan, Amlodipine Besilate)

Misaltantwin Tablet 80/5 mg (Telmisartan, Amlodipine Besilate)

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
YI Yeon Pharmaceutical Co., Ltd.
Appearance
Biconvex elliptical bilayer tablet in white and light blue color
Packaging
30 tablets/PTP (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201900722 · Approved 2019.01.30 · Insurance code 658603640

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this drug. However, direct switching to this drug may be considered if blood pressure is not controlled with the individual components, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
YI Yeon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively control blood pressure in patients with essential hypertension who do not achieve sufficient blood pressure control with monotherapy using Telmisartan or Amlodipine.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this drug. However, direct switching to this drug may be considered if blood pressure is not controlled with the individual components, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can pose serious risks to the fetus. Serious side effects such as decreased fetal kidney function, skull formation abnormalities, anuria, and renal failure may occur, and administration should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to certain patients. For example, it is contraindicated in individuals with allergies to the drug components, pregnant or nursing women, patients with severe liver dysfunction, patients with serious hypotension, and unstable heart failure after acute myocardial infarction. Some patients require special care during administration. Careful observation and dosage adjustment are necessary in patients with impaired liver function, gastrointestinal diseases, renal vascular diseases, elderly patients, and those with heart valve diseases. Common side effects may include dizziness and peripheral edema, while rare side effects can include fainting or severe allergic reactions. Additionally, symptoms of hypotension or electrolyte disturbances such as hyperkalemia may occur, necessitating periodic monitoring. This medication may interact with other drugs, so if other medications are being taken, it is essential to consult with a physician or pharmacist. Caution is particularly needed when used in combination with potassium supplements, diuretics, lithium, anticoagulants, certain antibiotics, and cardiac medications. Pregnant or nursing women should not take this medication, and those planning to become pregnant or already pregnant should switch to another safe antihypertensive treatment. The safety and efficacy of this medication for children have not been established, so it is not recommended. When administered to the elderly, careful observation is required due to possible differences in physical response, and dosage should be adjusted as necessary. In case of overdose, symptoms such as blood pressure reduction, dizziness, and irregular heart rhythms may occur, and immediate medical attention is required. This medication should be stored out of reach of children and must be kept in its original container to maintain quality; it should be opened just before administration.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormality
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • hepatic dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • polymorphous erythema
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • increased frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a special container that protects it from light. Additionally, it is important to store the medication at room temperature, between 1°C and 30°C, to maintain its effectiveness.

Appearance and packaging

Appearance

Biconvex elliptical bilayer tablet in white and light blue color

Package unit

30 tablets/PTP (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.